A serum-based DNA methylation assay provides accurate detection of glioma.
Saved in:
| Title: | A serum-based DNA methylation assay provides accurate detection of glioma. |
|---|---|
| Authors: | Sabedot TS; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA.; Omics Laboratory, Henry Ford Health System, Detroit, Michigan, USA., Malta TM; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA.; Omics Laboratory, Henry Ford Health System, Detroit, Michigan, USA., Snyder J; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA.; Omics Laboratory, Henry Ford Health System, Detroit, Michigan, USA.; Department of Neuro Oncology, Henry Ford Health System, Detroit, Michigan, USA., Nelson K; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA., Wells M; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA.; Omics Laboratory, Henry Ford Health System, Detroit, Michigan, USA., deCarvalho AC; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA., Mukherjee A; Department of Pathology, Henry Ford Health System, Detroit, Michigan, USA., Chitale DA; Department of Pathology, Henry Ford Health System, Detroit, Michigan, USA., Mosella MS; Omics Laboratory, Henry Ford Health System, Detroit, Michigan, USA., Sokolov A; Laboratory of Systems Pharmacology, Harvard Medical School, Boston, Massachusetts, USA., Asmaro KP; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA.; Omics Laboratory, Henry Ford Health System, Detroit, Michigan, USA., Robin A; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA., Rosenblum ML; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA., Mikkelsen T; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA., Rock J; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA., Poisson LM; Department of Public Health Sciences, Henry Ford Health System, Detroit, Michigan, USA., Lee I; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA., Walbert T; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA.; Department of Neuro Oncology, Henry Ford Health System, Detroit, Michigan, USA., Kalkanis S; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA., Iavarone A; Institute for Cancer Genetics, Department of Pathology and Cell Biology, Department of Neurology, Columbia University Medical Center, New York, New York, USA., Castro AV; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA.; Omics Laboratory, Henry Ford Health System, Detroit, Michigan, USA., Noushmehr H; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA.; Omics Laboratory, Henry Ford Health System, Detroit, Michigan, USA. |
| Source: | Neuro-oncology [Neuro Oncol] 2021 Sep 01; Vol. 23 (9), pp. 1494-1508. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
